Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial-Reference-Cited by-同舟云学术

Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trial

Published:2021-05 Issue:5 Volume:8 Page:e323-e333
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Howard Jo,Ataga Kenneth I,Brown Robert C,Achebe Maureen,Nduba Videlis,El-Beshlawy Amal,Hassab Hoda,Agodoa Irene,Tonda Margaret,Gray Sarah,Lehrer-Graiwer Joshua,Vichinsky Elliott

Publisher

Elsevier BV

Subject

Hematology

Reference25 articles.

1. Sickle cell disease;Kato;Nat Rev Dis Primers,2018

2. Sickle cell disease;Ware;Lancet,2017

3. Evidence-based management of sickle cell disease: expert panel report, 2014,2014

4. Hydroxyurea (hydroxycarbamide) for sickle cell disease;Nevitt;Cochrane Database Sys Rev,2017

5. Intravascular hemolysis and the pathophysiology of sickle cell disease;Kato;J Clin Invest,2017

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Position paper on advancing sickle cell disease management in France by bridging the clinical practices and guidelines through expert insights;Transfusion and Apheresis Science;2024-10

2. Fostering a healthier generation of children with sickle cell disease through advancements in care;Pediatric Research;2024-09-13

3. Doubling down on PK activation for sickle cell disease;Blood Advances;2024-08-27

4. Budget Impact of Disease-Modifying Treatments and a CRISPR Gene-Edited Therapy for Sickle Cell Disease;Clinical Drug Investigation;2024-08

5. Modulation of the allosteric and vasoregulatory arms of erythrocytic oxygen transport;Frontiers in Physiology;2024-06-10